Publications by authors named "Michael J Thorpy"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

335

Total Likes

120

Extended Reach

517,411

Social Features

100
C
Classification of sleep disorders.
Michael J Thorpy

Neurotherapeutics· October 2012

Videos about Article: user user

2 2 96 2 15

View All Article and Social Media Activity
U
Understanding idiopathic hypersomnia: diagnosis, pathophysiology, and management.
Madeeha Shahzadi, Renee Monderer, Michael J Thorpy

Curr Opin Pulm Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-Nightly Sodium Oxybate Meets American Academy of Sleep Medicine Criteria for Treatment of Narcolepsy.
Luis E Ortiz, Anne Marie Morse, Michael J Thorpy, Clete A Kushida, John Harsh

J Sleep Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How once-nightly sodium oxybate is processed in the body in healthy volunteers: a plain language summary.
Richard Bogan, Michael J Thorpy, Sarah Berkowitz, Jennifer Gudeman

J Comp Eff Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Dawn in the Management of Narcolepsy.
Michael J Thorpy, Anne Marie Morse

CNS Drugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Once-Nightly Sodium Oxybate in Patients with Narcolepsy: Post Hoc Analyses of Sensitivity, Effect Size, and Numbers Needed to Treat from the Phase 3 REST-ON Trial.
Thomas Roth, Michael J Thorpy, Clete A Kushida, Jennifer Gudeman

CNS Drugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Social support and isolation in narcolepsy and idiopathic hypersomnia: An international survey.
Julie Flygare, Lauren Oglesby, Sairam Parthasarathy, Michael J Thorpy, Emmanuel Mignot

Sleep Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial.
Michael J Thorpy, Clete A Kushida, Richard Bogan, Akinyemi O Ajayi, Bruce C Corser

Sleep Med X· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in sleep latency with extended-release once-nightly sodium oxybate for the treatment of adults with narcolepsy: Analysis from the phase 3 REST-ON clinical trial.
Michael J Thorpy, Clete A Kushida, Richard Bogan, John Winkelman, Maurice M Ohayon

Sleep Med X· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial.
Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J Thorpy, Anne Marie Morse

Sleep Med· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REM sleep in narcolepsy.
Michael J Thorpy, Jerome M Siegel, Yves Dauvilliers

Sleep Med Rev· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in daytime sleepiness and disrupted nighttime sleep with once-nightly sodium oxybate in people with narcolepsy type 1 and type 2: a plain language summary.
Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J Thorpy, Anne Marie Morse

J Comp Eff Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations in the treatment of idiopathic hypersomnia.
Michael J Thorpy, Lois Krahn, Chad Ruoff, Nancy Foldvary-Schaefer

Sleep Med· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations.
Anne Marie Morse, Richard K Bogan, Asim Roy, Michael J Thorpy

Neurol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brain fog in central disorders of hypersomnolence: a review.
Russell Rosenberg, Michael J Thorpy, Karl Doghramji, Anne Marie Morse

J Clin Sleep Med· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
Thomas Roth, Michael J Thorpy, Clete A Kushida, Matthew Horsnell, Jennifer Gudeman

J Comp Eff Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial.
Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J Thorpy, Anne Marie Morse

Sleep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia.
Anne Marie Morse, Yves Dauvilliers, Isabelle Arnulf, Michael J Thorpy, Nancy Foldvary-Schaefer

J Clin Sleep Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment.
Anne Marie Morse, Lois Krahn, Julie Flygare, Clete Kushida, Michael J Thorpy

Adv Ther· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
Richard K Bogan, Nancy Foldvary-Schaefer, Roman Skowronski, Abby Chen, Michael J Thorpy

CNS Drugs· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers.
Richard Bogan, Michael J Thorpy, John W Winkelman, Jordan Dubow, Jennifer Gudeman

Sleep Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical considerations for the diagnosis of idiopathic hypersomnia.
Yves Dauvilliers, Richard K Bogan, Isabelle Arnulf, Thomas E Scammell, Erik K St Louis, Michael J Thorpy

Sleep Med Rev· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy.
Michael J Thorpy, Danielle Hyman, Gregory S Parks, Abby Chen, Catherine Foley

Clin Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia.
Michael J Thorpy, Isabelle Arnulf, Nancy Foldvary-Schaefer, Anne Marie Morse, Karel Šonka

Nat Sci Sleep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario.
Haramandeep Singh, Danielle Hyman, Gregory S Parks, Abby Chen, Catherine Foley, Michael J Thorpy

Adv Ther· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
Yves Dauvilliers, Karel Šonka, Richard K Bogan, Markku Partinen, Rafael Del Rio Villegas, Michael J Thorpy

CNS Drugs· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis